Logo image of CLBR

COLOMBIER ACQUISITION CORP-A (CLBR) Stock Fundamental Analysis

NYSE:CLBR - New York Stock Exchange, Inc. - KYG2283U1004 - Common Stock - Currency: USD

10.75  0 (0%)

After market: 10.7216 -0.03 (-0.26%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CLBR. CLBR was compared to 0 industry peers in the Unkown industry. While CLBR has a great health rating, there are worries on its profitability. CLBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLBR was profitable.
CLBR Yearly Net Income VS EBIT VS OCF VS FCFCLBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M 4M

1.2 Ratios

Industry RankSector Rank
ROA 0.23%
ROE 0.24%
ROIC N/A
ROA(3y)1.9%
ROA(5y)N/A
ROE(3y)2.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLBR Yearly ROA, ROE, ROICCLBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 1 2 3

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CLBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLBR Yearly Profit, Operating, Gross MarginsCLBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

CLBR has less shares outstanding than it did 1 year ago.
CLBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLBR Yearly Shares OutstandingCLBR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
CLBR Yearly Total Debt VS Total AssetsCLBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 21.63 indicates that CLBR is not in any danger for bankruptcy at the moment.
There is no outstanding debt for CLBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.63
ROIC/WACCN/A
WACCN/A
CLBR Yearly LT Debt VS Equity VS FCFCLBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

CLBR has a Current Ratio of 2.39. This indicates that CLBR is financially healthy and has no problem in meeting its short term obligations.
CLBR has a Quick Ratio of 2.39. This indicates that CLBR is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.39
CLBR Yearly Current Assets VS Current LiabilitesCLBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

CLBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.74%.
EPS 1Y (TTM)-92.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLBR Yearly Revenue VS EstimatesCLBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
CLBR Yearly EPS VS EstimatesCLBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CLBR is valuated quite expensively with a Price/Earnings ratio of 537.50.
CLBR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
Industry RankSector Rank
PE 537.5
Fwd PE N/A
CLBR Price Earnings VS Forward Price EarningsCLBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLBR Per share dataCLBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COLOMBIER ACQUISITION CORP-A

NYSE:CLBR (2/21/2025, 8:09:56 PM)

After market: 10.7216 -0.03 (-0.26%)

10.75

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners78.41%
Inst Owner Change14.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap228.44M
Analysts0
Price TargetN/A
Short Float %0.37%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 537.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.02
EY0.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS8.06
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.23%
ROE 0.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.9%
ROA(5y)N/A
ROE(3y)2.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.39
Altman-Z 21.63
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.42%
OCF growth 3YN/A
OCF growth 5YN/A